Abstract
The history of anaesthesia contains many instances of strongly held beliefs which have subsequently not been substantiated. For example, many children died during anaesthesia because the particular difficulties associated with this age group were not appreciated and death was attributed to a condition named ‘status lymphaticus’ (1); it is clear now that no such condition exists. Similarly for many years it was argued that spinal anaesthesia led to irreversible damage to nerve tissue; this is now known to be avoidable (2). Also it was alleged that the administration of a general anaesthetic to an elderly person frequently led to irreversible central nervous system damage; this has now been refuted (3).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adriani, J., In: The pharmacology of anesthetic drugs, p. 126. Springfield (III.) 1952.
Dripps, R. D. & Vandam, L. D., Long term follow-up of patients who received 10,098 spinal anaesthetics; failure to discover major neurological sequelae. J. Amer. Med.Ass. 156, 1486 (1954).
Simpson, B. R., Williams, M., Scott, J. F. & Crampton-Smith, A., Lancet 2, 887 (1961).
Henderson, J. C. & Gordon, R. A., The incidence of post-operative jaundice with special reference to halothane. Can. Anaesth. Soc. J. 11, 453 (1964).
Raventos, J., The action of fluothane — a new volatile anaesthetic. Brit. J. Pharmacol. 11, 394 (1956).
Subcommittee of the National Academy of Sciences. J. Amer. med. Ass. 197, 775 (1966).
Dykes, M. H. M. & Bunker, J. P., Hepatotoxicity and anaesthetics. Pharmacol. Physicians 4, 1 (1970).
Mushin, W. W., Rosen, M. & Jones, E. V., Post-halothane jaundice in relation to previous administration of halothane. Brit. med. J. 1, 18 (1971).
Trey, C., Lipworth, L., Chalmers, T. C., Davidson, C. S., Gotlieb, L. S., Popper, H. & Saunders, S. J., Fulminant hepatic failure — presumably contribution of halothane. New Eng. J. Med., 279, 798 (1968).
Trey, C. & Davidson, C. S., Co-operative study of fulminant hepatitis. Clin. Res. 2, 462 (1969).
Peters, R. L., Edmonson, H. A., Reynolds, T. B., Meister, J. C. and Curphey, T. J., Hepatic necrosis associated with halothane anesthesia. Amer. J. Med., 47, 748 (1969).
Hughes, M. & Powell, L. W., Recurrent hepatitis in patients receiving multiple halothane anaesthetics for radium treatment of carcinoma of the cervix uteri. Gastroenterology 58, 790 (1970).
Sharpstone, P., Medley, D. R. K. & Williams, R., Halothane hepatitis — a preventable disease? Brit. med. J. 1, 448 (1971).
Hill, J. D., Halothane hepatitis. Brit. med. J. 2, 166 (1971).
Dykes, M. H. M., Unexplained post-operative fever — its value as a sign of halothane sensitization. J. Amer. med. Ass. 216, 641 (1971).
Dykes, M. H. M., Walzer, S. G., Slater, E. M., Gibson, J. M. & Ellis, D. S., Acute parenchymatous hepatic disease following general anaesthesia. J. Amer. med. Ass. 193, 339 (1965).
Sherlock, S., Progress report halothane hepatitis. Gut 12, 324 (1971).
Shulman, N. R., Hepatitis associated antigen. Amer. J. Med. 49, 669 (1970).
Wright, R., The Australia (hepatitis) antigen. Brit. J. Hosp. Med. 4, 75 (1970).
Doniach, D., Cell-mediated immunity in halothane hypersensitivity. New Eng. J. Med. 283, 315 (1970).
Mosley, J. W. & Galambos, J. T. In: Diseases of the liver, pp. 448, 451, 453. Philadelphia (Pa) 1959.
Inman, W. H. W., personal communication (1971).
Mushin, W. W., Rosen, M., Bowen, D. J. & Campbell, H., Halothane and liver dysfunction. A retrospective survey. Brit. med. J. 2, 329 (1964).
Gronert, G. A., Schaner, P. J. & Gunther, R. C., Multiple halothane anaesthesia in the burn patient. J. Amer. med. Ass. 205, 878 (1968).
Hege, M. J. D., Halothane anaesthesia in a patient with acute hepatic disease. Anesthesiology 32, 170 (1970).
Marx, G. F., Nagayoshi, M., Shoukas, J. A. & Wollman, S. B., Unsuspected infectious hepatitis in surgical patients. J. Amer. med. Ass. 205, 169 (1968).
Dykes, M. H. M. & Walzer, S. G., Pre-operative and post-operative hepatic dysfunction. Surg. Gynec. Obstet. 124, 747 (1967).
Klatskin, G., Toxic and drug induced hepatitis. In: Diseases of the Liver, 3rd edition, Philadelphia (Pa) & Toronto 1969.
Kopriva, C. J. & Lowenstein, E., An anaesthetic accident: cardiovascular collapse from liquid halothane delivery. Anesthesiology 30, 246–247 (1969).
Curelani, I., Stanciu, S. T., Nicolau, V., Fuhrer, H. & Iliescu, M., A case of recovery from coma produced by ingestion of 250 ml of halothane. Brit. J. Anaesth. 40, 283 (1968).
Van Dyke, R. A., Chenoweth, M. B. & Van Poznak, A., Metabolism of volatile anesthetics −1. Biochem. Pharmacol. 13, 1239 (1964).
Rehder, K., Forbes, J., Alter, H., Hessler, O. & Stier, A., Halothane biotransformation in man: a quantitative study. Anesthesiology 28, 711 (1967).
Britt, B. A. & Kalow, W., Malignant hyperthermia: a statistical review. Canad. Anaesth. Soc. J. 17, 293 (1970).
Airaksinen, M. M. & Tammisto, T., Toxic actions of the metabolites of halothane: LD50 and some metabolic effects of trifluoroethanol and trifluoroacetic acid in mice and guinea pigs. Ann. Med. exp. Fenn. 46, 242 (1968).
Cascorbi, H. F., Blake, D. A. & Helrich, M., Differences in the biotransformation of halothane in man. Anesthesiology 32, 119 (1970).
Cascorbi, H. F., Vesell, E. S., Blake, D. A. & Helrich, M., Genetic and environmental influence on halothane metabolism in twins. Clin. Pharm. Therapeut. 12, 50 (1970).
Harville, D. D. & Summerskill, W. H. J., Surgery in acute hepatitis: Causes and effects. J. Amer. med. Ass. 184, 257 (1963).
Blumberg, B. S., Sutnick, A. I., Londin, W. T. & Millman, I., Australia antigen and hepatitis. New Eng. J. Med. 283, 349 (1970).
Kantor, G. L. & Johnson, B. L., Cytomegalovirus infection associated with cardiopulmonary bypass. Arch. Int. Med. 125, 488 (1970).
Bunker, J. P. & Blumenfeld, C. M., Liver necrosis after halothane (Fluothane) anaesthesia. Cause or Coincidence? New Eng. J. Med. 268, 531 (1963).
Eisenstein, A. B., Aach, R. A., Jacobsohn, W. & Goldman, A., Infectious hepatitis in a general hospital. J. Amer. med. Ass. 185, 171 (1963).
Capps, R. B., Sborov, V. & Scheiffley, C. S., A syringe transmitted epidemic of infectious hepatitis. J. Amer. med. Ass. 136, 819 (1948).
Vickers, M. D. & Dinnick, O. P., Post-operative hepatic morbidity with special reference to the role of halothane. Anaesthesia 20, 29 (1966).
Park, S. K., Wallace, H. A., Brody, J. I. & Blakemore, W. S., Immunosuppressive effect of surgery. Lancet 1, 53 (1971).
Klion, F. M., Schaffner, F. & Popper, H., Hepatitis after exposure to halothane. Ann. Int. Med. 71, 467 (1969).
Uzunalimoglu, B., Yardley, J. H. & Boitnott, J. K., The liver in mild halothane hepatitis. Amer. J. Path. 61, 457 (1970).
Keeley, A. F., Trey, C., Marcon, N., Iseri, O. A. & Gottlieb, L. S., Anicteric halothane hepatitis: histologic and ultrastructural lesions associated with post-operative fever in two patients. Gastroenterology 58, 965 (1970).
Babior, B. M. & Davidson, C. S., Post-operative massive livernecrosis. A clinical and pathological study. New Eng. J. Med. 276, 645 (1967).
Rodriguez, M., Paronetto, F., Schaffner, F. & Popper, H., Antimitochondrial antibodies in jaundice following drug administration J. Amer. med. Ass. 208, 148 (1969).
Schumer, W., Erve, P. R., Obernolte, R. P., Bombeck, C. T. & Sadove, M. S., The effect of inhalation of halogenated anaesthetics on rat liver mitochondrial function. Anesthesiology 35, 253 (1971).
Teller, D. N., Denber, H. C. B. & Kopac, M. J., Binding of chlorpromazine and thioproperazine in vitro — 1. Bioch. Pharm. 16, 1397 (1967).
Sherlock, S., Diseases of the liver and biliary system, p. 374. Fourth ed. Oxford 1968.
Popper, H., Drug induced liver injury. Read before the New York State Society of Anesthesiologists. New York 1967.
Burns, T. H. S., Halothane hepatitis. Brit. med. J. 2, 523 (1971).
Paronetto, F. & Popper, H., Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane. New Eng. J. Med., 283, 277 (1970).
Doniach, D., Roitt, I. M., Walker, J. G. & Sherlock, S., Tissue antibodies in primary biliary cirrhosis, active chronic (lipoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin. exp. Immunol. 1, 237 (1966).
Klatskin, G. & Kimberg, D. N., Recurrent hepatitis attributable to halothane sensiti-sation in an anaesthetist. New Eng. J. Med. 280, 515 (1969).
Lancet 1, 1221 (1971). Management of chronic hepatitis — Leading article.
Linde, H. W. & Bruce, D. L., Halothane — occupational exposure. Anesthesiology 30, 363 (1969).
Hallen, B., Ehrner-Samuel, H. & Thomason, M., Measurements of halothane in the atmosphere of an operating theatre and in expired air and blood of the personnel during routine anaesthetic work. Acta anaesth. Scand. 14, 17 (1970).
Bruce, D. L., Eide, K. A., Linde, H. W. & Eckenhoff, J. E., Causes of death among anesthesiologists: a 20 year survey. Anesthesiology 29, 565 (1968).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1972 Leiden University Press, Leiden, The Netherlands
About this chapter
Cite this chapter
Simpson, B.R., Strunin, L., Walton, B. (1972). On the Toxicity of Halothane. In: Spierdijk, J., Feldman, S.A. (eds) Anaesthesia and Pharmaceutics. Boerhaave Series for Postgraduate Medical Education, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-2924-7_11
Download citation
DOI: https://doi.org/10.1007/978-94-010-2924-7_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-2926-1
Online ISBN: 978-94-010-2924-7
eBook Packages: Springer Book Archive